Sign In / Register
TGF-beta RI/ALK-5 Products
Most cell types express three sizes of receptors for TGF-beta. These are designated Type I (53 kDa), Type II (70 - 85 kDa), and Type III (250 - 350 kDa). The Type I receptor is a membrane-bound serine/threonine kinase that apparently requires the presence of the Type II receptor to bind TGF-beta. The Type II receptor is also a membrane-bound serine/threonine kinase that binds TGF-beta1 and TGF-beta 3 with high affinity and TGF-beta 2 with much lower affinity. The Type I and Type II receptors together form a heterodimeric signaling complex that is essential for the transduction of the anti-proliferative signals of TGF-beta. The Type III receptor is a transmembrane proteoglycan with a large extracellular domain and a 43 amino acid residue cytoplasmic domain. The cytoplasmic domain of the Type III receptor lacks an obvious signaling motif and the receptor may not be involved directly in signal transduction.
33 results for "TGF-beta RI/ALK-5" in Products
Application
Product Action
Conjugates
Clonality
Host Species
Isotype
Low Endotoxin
Sample Size
Citations
Reviews
TGF-beta RI/ALK-5 Products
Most cell types express three sizes of receptors for TGF-beta. These are designated Type I (53 kDa), Type II (70 - 85 kDa), and Type III (250 - 350 kDa). The Type I receptor is a membrane-bound serine/threonine kinase that apparently requires the presence of the Type II receptor to bind TGF-beta. The Type II receptor is also a membrane-bound serine/threonine kinase that binds TGF-beta1 and TGF-beta 3 with high affinity and TGF-beta 2 with much lower affinity. The Type I and Type II receptors together form a heterodimeric signaling complex that is essential for the transduction of the anti-proliferative signals of TGF-beta. The Type III receptor is a transmembrane proteoglycan with a large extracellular domain and a 43 amino acid residue cytoplasmic domain. The cytoplasmic domain of the Type III receptor lacks an obvious signaling motif and the receptor may not be involved directly in signal transduction.
33 results for "TGF-beta RI/ALK-5" in Products
Potent, selective inhibitor of TGF-βRI, ALK4 and ALK7
| Chemical Name : | 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide |
| Purity : | ≥99% (HPLC) |
Selective inhibitor of TGF-βRI, ALK4 and ALK7
| Chemical Name : | 3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide |
| Purity : | ≥98% (HPLC) |
Potent and selective inhibitor of TGF-βRI
| Alternate Names : | E-616452, SJN 2511, ALK5 Inhibitor II |
| Chemical Name : | 2-(3-(6-Methylpyridine-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine |
| Purity : | ≥99% (HPLC) |
Selective inhibitor of TGF-βRI
| Chemical Name : | 6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline |
| Purity : | ≥97% (HPLC) |
Catalog #:
TB1614-GMP
SB 431542 synthesized to cGMP guidelines
| Chemical Name : | 4-[4-(1,3-benzodioxol-5-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide |
| Purity : | ≥99% |
Flow
| Clonality : | Monoclonal |
| Host : | Rat IgG2a Clone #141231 |
| Applications : | Flow Cytometry |
Selective inhibitor of TGF-βRI
| Alternate Names : | HTS 466284 |
| Chemical Name : | 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]-quinoline |
| Purity : | ≥99% (HPLC) |
Potent and selective inhibitor of TGF-βRI
| Chemical Name : | 4-[2-Fluoro-5-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]phenyl]-1H-pyrazole-1-ethanol |
| Purity : | ≥98% (HPLC) |
Selective CK1 inhibitor. Also inhibits TGF-βRI
| Chemical Name : | 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide |
| Purity : | ≥99% (HPLC) |
ALK4 and ALK5 (TGFβRI) inhibitor
| Alternate Names : | LY 2157299 |
| Chemical Name : | 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide |
| Purity : | ≥98% (HPLC) |
WB, ELISA, ICC
| Clonality : | Polyclonal |
| Host : | Goat IgG |
| Applications : | ELISA, Immunocytochemistry/Immunofluorescence, Western Blot |
RepSox synthesized to Ancillary Material Grade
| Alternate Names : | ALK5 Inhibitor II, SJN 2511, E-616452 |
| Chemical Name : | 2-[3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine |
| Purity : | ≥99% |
BA
| Source : | NS0 |
| Accession # : | P36897 |
| Applications : | Bioactivity |
Selective inhibitor of TGF-βRI, ALK4 and ALK7
| Chemical Name : | 2-[4-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridine |
| Purity : | ≥98% (HPLC) |
Catalog #:
AVI3025
BA
Biotinylated
| Source : | HEK293 |
| Accession # : | P36897.1 |
| Applications : | Bioactivity |
Catalog #:
TB2939-RMU
A 83-01 synthesized to Ancillary Material Grade
| Chemical Name : | 3-(6-Methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-1H-pyrazole-1-carbothioamide |
| Purity : | ≥98% |
Catalog #:
AF587
WB
| Clonality : | Polyclonal |
| Host : | Goat IgG |
| Applications : | Western Blot |
Catalog #:
MAB5871R
WB
Recombinant Monoclonal Antibody.
| Clonality : | Monoclonal |
| Host : | Rat IgG2a Clone #141231R |
| Applications : | Western Blot |
Catalog #:
6016
Potent and selective inhibitor of TGF-βRI
| Chemical Name : | 3-[[5-(6-Methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1H-imidazol-2-yl]methyl]benzamide |
| Purity : | ≥98% (HPLC) |
Potent and selective inhibitor of TGF-βRI
| Chemical Name : | 4-[4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]-2-pyridinyl]-N-(tetrahydro-2H-pyran-4-yl)-benzamide |
| Purity : | ≥98% (HPLC) |
Catalog #:
6870
Potent TGF-βRI inhibitor
| Chemical Name : | 4-[[4-[(2.6-Dimethyl-3-pyridinyl)oxy]-2-pyridinyl]amino]benzenesulfonamide |
| Purity : | ≥98% (HPLC) |
Potent ATP-competitive TGF-βRI inhibitor
| Chemical Name : | 2-(5-Chloro-2-fluorophenyl)-4-[(4-pyridyl)amino]pteridine |
| Purity : | ≥98% (HPLC) |
Catalog #:
6712
Potent inhibitor of TGF-βRI
| Chemical Name : | 4-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]quinoline |
| Purity : | ≥98% (HPLC) |
Catalog #:
MAB587
WB
| Clonality : | Monoclonal |
| Host : | Rat IgG2a Clone #141229 |
| Applications : | Western Blot |
WB
| Clonality : | Polyclonal |
| Host : | Goat IgG |
| Applications : | Western Blot |
